IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.

560.36 13.18 +2.41%
Market cap
$43.1B
P/E
39.1×
Fwd P/E
38.3×
Dividend yield
—
F-score
8/9
Altman Z
24.09
Beneish M
−2.50
Dividend safety
n/a

IDEXX Laboratories, Inc. (IDXX) Book value per share

Alert me on Book value per share

IDEXX Laboratories, Inc.'s book value per share at the end of fiscal 2025 was 20.0×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 20.4×. Over the past ten years it has ranged from −1.2× (fiscal 2016) to 20.0× (fiscal 2025) — the current reading is the highest in ten years. IDEXX Laboratories, Inc. ranks 13th of 52 Diagnostics & Research companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 20.0× 3.18%
FY2024 19.3× 8.24%
FY2023 17.9× 145.51%
FY2022 7.3× (10.11%)
FY2021 8.1× 9.22%
FY2020 7.4× 259.07%
FY2019 2.1× —
FY2018 −0.1× —
FY2017 −0.6× —
FY2016 −1.2× —

Quarterly newest first

Period Book value per share Change
Jun 2026 20.4× 4.54%
Mar 2026 19.5× (2.12%)
Dec 2025 20.0× 2.41%
Sep 2025 19.5× 7.44%
42 more quarters

Against its own ten years

Low −1.2× High 20.0×
Ten-year median 7.3×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on IDXX